Venetoclax in relapsed/refractory blastic plasmacytoid dendritic cell neoplasm with central nervous system involvement: a case report and review of the literature
ConclusionsVenetoclax monotherapy seems not enough to control the disease progression under CNS involvement and other treatments should be investigated.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Chemotherapy | General Medicine | Leukemia | Skin | Stem Cell Therapy | Stem Cells | Transplants